The Diagnostic Path: How RORC Deficiency is Confirmed
At a Glance
Complete RORC deficiency can be missed by routine blood tests because white-cell counts and antibody levels may be normal. Diagnosis combines specialized immune-cell counting, IFN-gamma and IL-17 response tests, mycobacterial testing, and sequencing both copies of the RORC gene.
The diagnosis of complete RORC deficiency is rarely made with a single blood draw. Because this condition is so rare, your medical team will likely use a “layered” approach to testing. This process moves from broad screening to highly specialized functional tests, finally concluding with a genetic assessment interpreted by experts [1][2].
The Challenge of “Normal” Results
One of the most confusing parts of this journey is that many standard hospital tests may come back completely normal. In children with RORC deficiency, the following are often within the typical range [3][4]:
- Complete Blood Count (CBC): The total number of white blood cells is usually normal.
- Total Lymphocyte Count: The total number of T cells and B cells may look fine.
- Immunoglobulins (IgG, IgA, IgM): The levels of antibodies your child produces are typically normal [5].
Because these “routine” tests don’t show the problem, doctors must look deeper into the specific types and behaviors of the immune cells.
Specialized Testing: The “Immune Signature”
To find the “blind spots” in the immune system, specialists use three main types of advanced testing. Note: Not every patient needs every test, and an immunologist must interpret these results using age-adjusted ranges, as normal values change as a child grows.
1. Flow Cytometry (Counting the “Specialists”)
This test uses lasers to count very specific subtypes of immune cells. In a child with complete RORC deficiency, several key groups are missing or severely depleted [1]:
- MAIT and iNKT Cells: These “innate-like” T cells are often nearly completely gone. They are the frontline defenders against many types of germs.
- Th17 and Th1 Cells*: These specialized helper cells are usually very low. Th17 cells are needed to fight yeast (Candida), and Th1* cells help fight mycobacteria [1][2].
- CD8+ T Cells: These may also be lower than expected for the child’s age [1].
2. Functional Assays (Testing the Response)
These tests don’t just count cells; they see if the cells “work” when they encounter a germ. Laboratories choose validated stimuli for these tests, and results can vary based on the specific lab and assay used.
- The IFN-gamma Assay: Scientists mix your child’s blood with mycobacteria and measure how much interferon-gamma (IFN-
) is produced. In RORC deficiency, this production is significantly impaired, though not always completely absent [1][6]. (Note: This is a specialized research or immunology lab assay, not the standard tuberculosis IGRA test). - The IL-17 Assay: Similarly, the blood is tested to see if it can produce IL-17A and IL-17F. In this condition, these signaling proteins are typically severely reduced or absent, which explains the persistent thrush and yeast infections [2][7].
3. Genetic Sequencing
The diagnosis is confirmed through genetic sequencing of the RORC gene [2].
- Biallelic Variants: To have the condition, the child must have variants on both copies of the gene. These can be homozygous (the exact same variant inherited from both parents) or compound heterozygous (two different variants, one from each parent) [1].
- Pathogenicity: The genetic variants must be classified by experts as “pathogenic” or “likely pathogenic” and must fit the child’s clinical symptoms and lab results. A “variant of uncertain significance (VUS)” is not enough to confirm the diagnosis without further testing [8].
Your Diagnostic Completeness Checklist
If you are reviewing your child’s medical records with your specialist, these are the types of data points they are evaluating [6][9]:
| Test Category | What It Is Looking For | Why It Matters |
|---|---|---|
| Microbiology | Mycobacterial Culture / PCR | Confirms if an active infection is the BCG strain or an environmental mycobacterium. |
| Cell Counting | Flow Cytometry for MAIT and iNKT | These are the most characteristic “missing” cells in RORC deficiency. |
| Functional | IFN- |
Shows if the “bacterial” and “fungal” guards are impaired. |
| Molecular | Biallelic RORC gene variants | Genetic confirmation of the underlying cause. |
Glossary of Terms:
- RORC/ROR
/ROR t: The gene and the resulting proteins that act as master switches for immune cell development. - MAIT / iNKT: Specialized “innate-like” T cells that rapidly respond to bacterial threats.
- Th17 / Th1*: Helper T cells that produce critical immune defense proteins.
Common questions in this guide
Can normal blood counts rule out complete RORC deficiency?
What can flow cytometry show in complete RORC deficiency?
How does the IFN-gamma test help diagnose RORC deficiency?
What does IL-17 testing show in complete RORC deficiency?
What genetic result confirms complete RORC deficiency?
Why are mycobacterial culture and PCR included in the evaluation?
One line in your results can change your plan.
A "variant of uncertain significance" is not enough to confirm the diagnosis without further testing. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
Human inherited RORγT deficiency encompasses genetic heterogeneity, T cell deficiency, and clinical homogeneity.
Fagniez I, Tsumura M, Guerin A, et al.
medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.07.18.26358075.
PMID: 42539146 - 2
IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.
Okada S, Markle JG, Deenick EK, et al.
Science (New York, N.Y.) 2015; (349(6248)):606-613 doi:10.1126/science.aaa4282.
PMID: 26160376 - 3
Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings.
Cornelissen H, Glanzmann B, van Coller A, et al.
The journal of allergy and clinical immunology. Global 2025; (4(4)):100540 doi:10.1016/j.jacig.2025.100540.
PMID: 41048447 - 4
An Updated Review on MSMD Research Globally and A Literature Review on the Molecular Findings, Clinical Manifestations, and Treatment Approaches in China.
Xia L, Liu XH, Yuan Y, et al.
Frontiers in immunology 2022; (13()):926781 doi:10.3389/fimmu.2022.926781.
PMID: 36569938 - 5
Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
Zhang W, Chen X, Gao G, et al.
Frontiers in immunology 2021; (12()):654406 doi:10.3389/fimmu.2021.654406.
PMID: 33777053 - 6
Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India.
Dalvi A, Temkar L, Desai M, et al.
Journal of human immunity 2026; (2(1)):e20250153 doi:10.70962/jhi.20250153.
PMID: 42170591 - 7
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.
Okada S, Puel A, Casanova JL, Kobayashi M
Clinical & translational immunology 2016; (5(12)):e114 doi:10.1038/cti.2016.71.
PMID: 28090315 - 8
Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.
van Coller A, Glanzmann B, Cornelissen H, et al.
BMC immunology 2021; (22(1)):62 doi:10.1186/s12865-021-00452-6.
PMID: 34517836 - 9
What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.
Johnston AΜ, Rider NL, Freeman AF, et al.
The journal of allergy and clinical immunology. In practice 2026; (14(7)):1529-1539 doi:10.1016/j.jaip.2026.02.026.
PMID: 41786143
This page is for informational purposes only and does not constitute medical advice. An immunologist and genetics team should interpret your child's complete RORC deficiency testing in clinical context.